JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPANO, P. F.
Right arrow Articles by COSTA, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPANO, P. F.
Right arrow Articles by COSTA, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 174, Issue 1, 20-26, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


EFFLUX OF CHLORPROMAZINE AND TRIFLUOPERAZINE FROM THE RAT BRAIN

P. F. SPANO 1, N. H. NEFF 1, E. MACKO 1, and E. COSTA 1

1 Departments of Pharmacology and Neurology, College of Physicians and Surgeons of Columbia University, New York, New York; Smith Kline and French Laboratories, Philadelphia, Pennsylvania

Chlorpromazine (CPZ) and trifluoperazine (TFP) attained equal concentrations in rat brain one hour after an i.v. injection of 4.2 µmol/kg, and both declined at similar rates. After 42 µmol/kg, both drugs again attained equal concentrations in brain at one hour, but only TFP declined as it did after the low dose. CPZ declined rapidly at first and then more slowly. The hypothermic and hypotensive properties of CPZ were not responsible for the altered kinetics. Administering CPZ sulfoxide, 42 µmol/kg, prior to a low dose of CPZ or TFP slowed their efflux from brain. CPZ sulfoxide concentrations in plasma were always higher and declined slower than TFP sulfoxide when the parent compounds were administered in equal doses. Moreover, CPZ sulfoxide inhibited the metabolism of CPZ in a liver homogenate. CPZ metabolites probably accumulated after the high dose and retarded further CPZ metabolism, thereby delaying its disappearance from brain.

Submitted on October 31, 1969
Accepted on March 24, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.